{"company":{"id":2157257,"name":"Aeovian","domain":"aeovian.com","url":"https://alion.io/company/aeovian"},"section":"news","answer":"Aeovian: 6 headlines on record, 0 headlines in the last 90 days. Its story counts 1 milestone.","figures":[{"label":"Headlines","value":"6"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"1"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":6},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":1}],"news":[{"date":"2025-12-27","kind":"News","title":"Aeovian Pharmaceuticals: $55 Million Series B Raised To Advance AV078 For Tuberous Sclerosis Complex-Related Refractory Epilepsy","source":"Pulse 2.0","url":"https://pulse2.com/aeovian-pharmaceuticals-55-million-series-b/"},{"date":"2025-12-16","kind":"News","title":"TSC Alliance Endowment Fund Invests in Aeovian Pharmaceuticals to Advance Development of an mTORC1 Selective Inhibitor for Tuberous Sclerosis Complex","source":"YahooFinance","url":"https://finance.yahoo.com/news/tsc-alliance-endowment-fund-invests-130000690.html"},{"date":"2024-04-03","kind":"News","title":"Aeovian Pharmaceuticals: $50 Million Raised To Develop Selective Therapeutics For Restoring Cellular Metabolic Quality Control","source":"Pulse 2.0","url":"https://pulse2.com/aeovian-pharmaceuticals-50-million-raised-to-develop-selective-therapeutics-for-restoring-cellular-metabolic-quality-control/"},{"date":"2024-03-28","kind":"Press release","title":"AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN PHASE 1 CLINICAL TRIAL, STRENGTHENS LEADERSHIP TEAM AND RAISES ADDITIONAL $50 MILLION FINANCING","source":"PRNewswire","url":"https://prnewswire.com/news-releases/aeovian-pharmaceuticals-doses-first-participants-in-phase-1-clinical-trial-strengthens-leadership-team-and-raises-additional-50-million-financing-302101427.html"},{"date":"2023-12-26","kind":"News","title":"Aeovian Pharmaceuticals patents CD38 inhibitors","source":"bioworld.com","url":"https://bioworld.com/articles/704049-aeovian-pharmaceuticals-patents-cd38-inhibitors?v=preview"},{"date":"2019-10-12","kind":"News","title":"Aeovian raises $37 million for mTORC1 inhibitors","source":"Chemical & Engineering News","url":"https://cen.acs.org/pharmaceuticals/drug-discovery/Aeovian-raises-37-million-mTORC1/97/i40"}],"story":[{"title":"Raised a round Venture round $37M · Chemical & Engineering News","url":"https://cen.acs.org/pharmaceuticals/drug-discovery/Aeovian-raises-37-million-mTORC1/97/i40"}],"as_of":"2026-11-17","cite":"Aeovian, News. Alion, Nov 17, 2026. https://alion.io/company/aeovian/news","html_url":"https://alion.io/company/aeovian/news","json_url":"https://alion.io/company/aeovian/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T09:12:15Z"}}